JAC Advance Access published online on August 13, 2003
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkg360
© 2003 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brief report
1 Infectious Diseases Research Laboratory, Infectious Diseases
Division, Hospital Universitari Vall d'Hebron, Universitat
Autònoma de Barcelona, Avda. Vall d'Hebron, 119-129,
08035 Barcelona, Spain
* Corresponding author. E-mail: gavalda{at}hg.vhebron.es.
Received 24 March 2003
; revised 4 June 2003
; accepted 6 June 2003
Objective: This study tests the usefulness
of ceftriaxone combined with ampicillin as an alternative to ampicillin
plus gentamicin for the treatment of experimental endocarditis due
to Enterococcus faecalis without high-level resistance
to aminoglycosides. It also determines whether adding ceftriaxone
to ampicillin and gentamicin increases the effectiveness against
experimental enterococcal endocarditis resulting from
E. faecalis. Methods: Animals with catheter-induced endocarditis
were infected intravenously with 108 cfu of the EF91 strain
of E. faecalis and were treated for 3 days with
ampicillin 2 g every 4 h administered as human-like'
(H-L) pharmacokinetics, plus gentamicin 1 mg/kg every 8 h
H-L, or ceftriaxone 2 g every 12 h H-L alone or combined with gentamicin
6 mg/kg every 24 h administered subcutaneously. Results: The results of therapy for experimental
endocarditis resulting from EF91 showed that the combination of
ampicillin plus ceftriaxone was as effective as ampicillin plus
gentamicin. The triple combination did not improve on the overall
efficacies of the two-drug combinations. Conclusions: Because of its lower nephrotoxicity,
ampicillin plus ceftriaxone may be a useful alternative therapy
for E. faecalis endocarditis in selected patients.
Keywords: bacteria, intravascular infections, animal models,
antibiotic combinations
Efficacy of ampicillin combined with ceftriaxone
and gentamicin in the treatment of experimental endocarditis due
to Enterococcus faecalis with no high-level resistance
to aminoglycosides
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. Euba, J. Lora-Tamayo, O. Murillo, S. Pedrero, J. Cabo, R. Verdaguer, and J. Ariza Pilot Study of Ampicillin-Ceftriaxone Combination for Treatment of Orthopedic Infections Due to Enterococcus faecalis Antimicrob. Agents Chemother., October 1, 2009; 53(10): 4305 - 4310. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gavalda, O. Len, B. Almirante, and A. Pahissa Ampicillin plus Ceftriaxone for High-Level Aminoglycoside-Resistant Enterococcus faecalis Endocarditis Ann Intern Med, February 5, 2008; 148(3): 243 - 243. [Full Text] [PDF] |
||||
![]() |
J. Gavalda, O. Len, J. M. Miro, P. Munoz, M. Montejo, A. Alarcon, J. de la Torre-Cisneros, C. Pena, X. Martinez-Lacasa, C. Sarria, et al. Brief Communication: Treatment of Enterococcus faecalis Endocarditis with Ampicillin plus Ceftriaxone Ann Intern Med, April 17, 2007; 146(8): 574 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hoen Epidemiology and antibiotic treatment of infective endocarditis: an update. Heart, November 1, 2006; 92(11): 1694 - 1700. [Full Text] [PDF] |
||||


